CNC vs JNJ · P/E 8.4, rev $103.52B vs P/E 17, rev $49.37B
Centene Corp (CNC) versus Johnson & Johnson (JNJ) — a side-by-side from cached financials, not a winner call.
Centene Corp (CNC) is a healthcare plans company listed on US.
Johnson & Johnson (JNJ) is a drug manufacturers - general company listed on US. It is led by Joaquin Duato.
Latest reported CNC revenue for 2026-06-30 was $103.52B. Net income was $2.63B. CNC currently screens at market cap $28.19B and trailing P/E 8.4.
Latest reported JNJ revenue for 2026-06-28 was $49.37B. Net income was $10.77B. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
CNC currently screens at market cap $28.19B and trailing P/E 8.4. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
Not investment advice. Open the CNC and JNJ stock pages for the full models.
Not investment advice.